Abstract6-Oxopurine derivatives containing a northern (N) methanocarba modification (i.e., fused cyclopropane and cyclopentane rings in place of the ribose) were synthesized and the adenosine receptor affinity measured. Guanine or hypoxanthine was coupled at the 7-position, or 1,3-dibutylxanthine was coupled at the 9-position. The pseudoribose ring was also substituted at the 5′-position with an N-methyluronamide or with phosphate groups.We recently examined conformational requirements of the ribose moiety in adenosine derivatives acting as agonists or partial agonists at P2 receptors and at subtypes of adenosine receptors (A 1 , A 2A , and A 3 ARs). 1-3 Using a methanocarba modification originally introduced by Marquez and co-workers, 4 the ribose-like moiety of these derivatives was constrained to either a northern [(N), 2′-exo] or southern [(S), 2′-endo] conformation through fused cyclopropane and cyclopentane rings. Such analogues helped to define the role of ribofuranosyl puckering in stabilizing the active AR-bound conformation, and thereby allowed identification of the (N)-methanocarba conformation as the isomer which preserved affinity at the A 3 and to a lesser extent, A 1 AR. Thus, the (N)-methanocarba analogues, 1 and 2, were highly potent as full agonist (2) 3 or partial agonist (1) at the human A 3 AR. 2 These analogues contained substituent groups known to enhance A 3 affinity in the ribose series [i.e., N 6 -(3-iodobenzyl) and 2-chloro]. The affinity of adenosine methanocarba analogues at the A 2A AR was greatly decreased for the (N)-methanocarba isomer and nearly absent for the (S)-methanocarba isomer.In this study, we combined the (N)-methanocarba modification with known purine receptor ligands containing a 6-oxo-substitution. Among the nucleoside analogues synthesized were derivatives of hypoxanthine, guanosine, and xanthine. For inosine 5,6 and xanthine-7-riboside 7 analogues, a 5′-methyluronamide modification (nucleoside numbering) known to enhance the A 3 AR affinity was included. 3,5 In comparison, xanthine-7-riboside derivatives 3 and 4 bound to and activated the rat A 3 AR with partial or full efficacy, respectively, 7,8 and